0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > MOG

MOG

Brief Information

Name:Myelin-oligodendrocyte glycoprotein
Target Synonym:NRCLP7,Myelin-oligodendrocyte glycoprotein,MOG,Myelin Oligodendrocyte Glycoprotein,MOG Ig-AluB,MOG Alpha-5,MOG AluA,MOG AluB,BTNL11,MOGIG2,BTN6
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Par statut du produit :
Par catégorie de produit :
Par espèce :
Cat . Non Espèces Description du produit Structure Pureté Caractéristique
MOG-M82E7 Mouse Biotinylated Mouse MOG Protein, His,Avitag™ (MALS verified)
MOG-M82E7-structure
MOG-M82E7-sds
MOG-H82E5 Human Biotinylated Human MOG Protein, His,Avitag™ (MALS verified)
MOG-H82E5-structure
MOG-H82E5-sds
MOG-H52H3 Human Human MOG Protein, His Tag (MALS verified)
MOG-H52H3-structure
MOG-H52H3-sds
ACRO Quality

Part of Bioactivity data

MOG-M82E7-MALS-HPLC
MOG MALS images

The purity of Biotinylated Mouse MOG Protein, His,Avitag (Cat. No. MOG-M82E7) is more than 90% and the molecular weight of this protein is around 18-26 kDa verified by SEC-MALS.

MOG-H82E5-MALS-HPLC
MOG MALS images

The purity of Biotinylated Human MOG Protein, His,Avitag (Cat. No. MOG-H82E5) is more than 90% and the molecular weight of this protein is around 17-25 kDa verified by SEC-MALS.

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
MOG autologous T-lymphocyte cell therapy (ImCyse) Phase 2 Clinical Imcyse Sa Multiple Sclerosis Details
MOG autologous T-lymphocyte cell therapy (ImCyse) Phase 2 Clinical Imcyse Sa Multiple Sclerosis Details

This web search service is supported by Google Inc.

totop

Laisser un message